US 12042479
Use of topical formulations of cannabinoids in the treatment of epidermolysis bullosa and related connective tissue disorders
granted A61KA61K31/045A61K31/05
Quick answer
US patent 12042479 (Use of topical formulations of cannabinoids in the treatment of epidermolysis bullosa and related connective tissue disorders) held by INMED PHARMACEUTICALS INC. expires Mon Jul 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- INMED PHARMACEUTICALS INC.
- Grant date
- Tue Jul 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/045, A61K31/05, A61K31/352, A61K31/658